Clinical Trial Update: Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study. [Phase 1, Phase 2]

View source ↗

Summary

Multi-center, single-arm Phase I/II clinical trial assessing safety and preliminary efficacy of apatinib mesylate in combination with an irinotecan-temozolomide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Apatinib Mesylate (apatinib)
• Irinotecan (Irinotecan)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Neuroblastoma | Phase 1, Phase 2 | Status: RECRUITING